PROFESSIONAL EDITION

The largest community of pharma leaders

TFF Pharmaceuticals Raises $8.17 Million and Expands Leadership Team with New CFO and Director Appointments

AUSTIN, Texas–(BUSINESS WIRE)–TFF Pharmaceuticals announces completion of $8.17 Million Series A Preferred Stock; New Chief Financial Officer and Director are appointed.

 

 

 

 

http://www.businesswire.com/news/home/20190530005360/en/TFF-Pharmaceuticals-Raises-8.17-Million-Expands-Leadership/

Recent Articles